Dawn Kelly-Sullivan

Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice

Audrey L. Hildebrandt, Dawn Kelly-Sullivan, Shawn C. Black · European Journal of Pharmacology · 2003 · 181 citations

Obesity, Nutrition, Metabolic Syndrome +9

RANDOMIZED CLINICAL TRIAL OF ANTITHYMOCYTE GLOBULIN INDUCTION IN RENAL TRANSPLANTATION COMPARING A FIXED DAILY DOSE WITH DOSE ADJUSTMENT ACCORDING TO T CELL MONITORING

George M. Abouna, Ismail H. Al-Abdullah, Dawn Kelly-Sullivan et al. · Transplantation · 1995 · 60 citations · Full text

Antithymocyte Globulin, Cell Therapy, Immunodeficiencies +21

RANDOMIZED CLINICAL TRIAL OF ANTITHYMOCYTE GLOBULIN INDUCTION IN RENAL TRANSPLANTATION COMPARING A FIXED DAILY DOSE WITH DOSE ADJUSTMENT ACCORDING TO T CELL MONITORING

George M. Abouna, Ismail H. Al-Abdullah, Dawn Kelly-Sullivan et al. · Transplantation · 1995 · 55 citations

Antithymocyte Globulin, Cell Therapy, Immunology +19

New bicyclic cannabinoid receptor-1 (CB1-R) antagonists

Philip A. Carpino, David A. Griffith, Subas M. Sakya et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 42 citations · Full text

Cannabis Use, Molecular Pharmacology, Functional Selectivity +7

Identification of a PCSK9-LDLR disruptor peptide with in vivo function

Margaret E. Brousseau, Kevin B. Clairmont, Glen Spraggon et al. · Cell chemical biology · 2021 · 42 citations

Inflammation, Signal Transduction, Peptide Library +7